Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication

We are furnishing herewith newspaper Publication in respect of transfer of Equity Shares of the Company against which dividend remain unpaid/unclaimed for 7 conservative years, to Investor Education and Protection Fund (IEPF) pursuant to Rule 6 of the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, which have been published in the following newspapers: 1.Business Standard (English-all editions) dated 15.07.2020. 2.Desh Sewak (Punjabi) dated 15.07.2020
15-07-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Disclosure Under Regulation 30 (LODR) Read With SEBI Circular Dated 20-05-2020

This is with reference to SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020 issued by the Securities and Exchange Board of India (SEBI). In this regard, please find attached herewith update on Impact of the CoVID-19 pandemic on the Company.
14-07-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Shareholding for the Period Ended June 30, 2020

Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here
04-07-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Statement Of Investor Complaints For The Quarter Ended June 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Sukriti SainiDesignation :- Company Secretary and Compliance Officer
03-07-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Closure of Trading Window

Pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and in continuation to our letter No. NLL/CS/2020-H dated 31st March, 2020, we wish to inform you that the trading window of the Company will further continue to be closed till 48 hours after the declaration of Financial Results for the Financial year 2019-20 or for the quarter ended on June 30, 2020, whichever is later.
30-06-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Clarification

With reference to Movement in Price, Nectar Lifesciences Ltd has submitted to BSE a copy of Clarification is enclosed.
19-06-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Clarification sought from Nectar Lifesciences Ltd

The Exchange has sought clarification from Nectar Lifesciences Ltd on June 19, 2020, with reference to Movement in Price.The reply is awaited.
19-06-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Disclosure Under Regulation 30 Of Securities & Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015.

This is to inform you that the Board of Directors have resolved to change the designation of Dr. Dinesh Dua, Wholetime Director from Chief Executive Officer & Director ('CEO') to Executive Director ('ED') vide its resolution dated May 20, 2020. This change in designation of Dr. Dua from CEO to ED is for internal administrative purposes only. There is not any change in his statutory designation of Wholetime Director, which he will be continuing as it is.
20-05-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find attached herewith the Annual Secretarial Compliance Report for the year ended on March 31, 2020 duly signed by Company Secretary in practice.
11-05-2020
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find attached herewith the Annual Secretarial Compliance Report for the year ended on March 31, 2020 duly signed by Company Secretary in practice.
11-05-2020
Next Page
Close

Let's Open Free Demat Account